Search

everythinglearnresearchcommunity

for

Search:↓

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

A protein complex called mTORC1 likely affects when hair growth starts in mice.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Topical melatonin may reduce skin aging by inhibiting certain cellular pathways.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Tacrolimus can cause hair loss in kidney transplant patients.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

A woman developed thick gums from everolimus treatment after a kidney transplant.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.